{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:05:27Z","timestamp":1793675127606,"version":"4.5.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,5,31]],"date-time":"2015-05-31T00:00:00Z","timestamp":1433030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00417-015-3056-5","type":"journal-article","created":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T05:39:18Z","timestamp":1432964358000},"page":"1705-1712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of epitheliotrophic factors in autologous serum eyedrops from sera of chronic renal failure patients vs. normal controls"],"prefix":"10.1007","volume":"253","author":[{"given":"Na Hee","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shina","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roo Min","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,31]]},"reference":[{"key":"3056_CR1","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/bjo.2004.044347","volume":"88","author":"G Geerling","year":"2004","unstructured":"Geerling G, Maclennan S, Hartwig D (2004) Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 88:1467\u20131474","journal-title":"Br J Ophthalmol"},{"key":"3056_CR2","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/ICO.0b013e31817f3a0e","volume":"27","author":"T Kojima","year":"2008","unstructured":"Kojima T, Higuchi A, Goto E, Matsumoto Y, Dogru M, Tsubota K (2008) Autologous serum eye drops for the treatment of dry eye diseases. Cornea 27:S25\u201330","journal-title":"Cornea"},{"key":"3056_CR3","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1167\/iovs.05-0876","volume":"47","author":"L Liu","year":"2006","unstructured":"Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Kasper K, Geerling G (2006) Corneal epitheliotrophic capacity of three different blood-derived preparations. Invest Ophthalmol Vis Sci 47:2438\u20132444","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3056_CR4","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s00417-004-1106-5","volume":"243","author":"L Liu","year":"2005","unstructured":"Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Geerling G (2005) An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol 243:706\u2013714","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3056_CR5","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/ICO.0b013e3182542085","volume":"31","author":"KR Fischer","year":"2012","unstructured":"Fischer KR, Opitz A, B\u00f6eck M, Geerling G (2012) Stability of serum eye drops after storage of 6\u00a0months. Cornea 31:1313\u20131318","journal-title":"Cornea"},{"key":"3056_CR6","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/ICO.0000000000000109","volume":"33","author":"V Freire","year":"2014","unstructured":"Freire V, Andollo N, Etxebarria J, Hern\u00e1ez-Moya R, Dur\u00e1n JA, Morales MC (2014) Corneal wound healing promoted by 3 blood derivatives: an in vitro and in vivo comparative study. Cornea 33:614\u2013620","journal-title":"Cornea"},{"key":"3056_CR7","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1167\/iovs.11-7340","volume":"53","author":"V Freire","year":"2012","unstructured":"Freire V, Andollo N, Etxebarria J, Dur\u00e1n JA, Morales MC (2012) In vitro effects of three blood derivatives on human corneal epithelial cells. Invest Ophthalmol Vis Sci 53:5571\u20135578","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3056_CR8","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/ICO.0000000000000271","volume":"33","author":"M Hussain","year":"2014","unstructured":"Hussain M, Shtein RM, Sugar A, Soong HK, Woodward MA, DeLoss K, Mian SI (2014) Long-term use of autologous serum 50-% eye drops for the treatment of dry eye disease. Cornea 33:1245\u20131251","journal-title":"Cornea"},{"key":"3056_CR9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3109\/02713683.2011.587935","volume":"36","author":"N Phasukkijwatana","year":"2011","unstructured":"Phasukkijwatana N, Lertrit P, Liammongkolkul S, Prabhasawat P (2011) Stability of epitheliotrophic factors in autologous serum eye drops from chronic Stevens-Johnson syndrome dry eye compared to non-autoimmune dry eye. Curr Eye Res 36:775\u2013781","journal-title":"Curr Eye Res"},{"key":"3056_CR10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1442-9071.2008.01895.x","volume":"36","author":"JC Bradley","year":"2008","unstructured":"Bradley JC, Bradley RH, McCartney DL, Mannis MJ (2008) Serum growth factor analysis in dry eye syndrome. Clin Experiment Ophthalmol 36:717\u2013720","journal-title":"Clin Experiment Ophthalmol"},{"key":"3056_CR11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-2008-1027199","volume":"225","author":"S Harloff","year":"2008","unstructured":"Harloff S, Hartwig D, Kasper K, Wedel T, M\u00fcller M, Geerling G (2008) Epitheliotrophic capacity of serum eye drops from healthy donors versus serum from immunosuppressed patients with rheumatoid arthritis. Klin Monbl Augenheilkd 225:200\u2013206, Article in German","journal-title":"Klin Monbl Augenheilkd"},{"key":"3056_CR12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.0958-7578.2005.00559.x","volume":"15","author":"D Hartwig","year":"2005","unstructured":"Hartwig D, Herminghaus P, Wedel T, Liu L, Schlenke P, Dibbelt L, Geerling G (2005) Topical treatment of ocular surface defects: comparison of the epitheliotrophic capacity of fresh frozen plasma and serum on corneal epithelial cells in an in vitro cell culture model. Transfus Med 15:107\u2013113","journal-title":"Transfus Med"},{"key":"3056_CR13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1350-9462(99)00007-5","volume":"19","author":"J Imanishi","year":"2000","unstructured":"Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S (2000) Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res 19:113\u2013129","journal-title":"Prog Retin Eye Res"},{"key":"3056_CR14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.exer.2004.07.008","volume":"79","author":"B Klenkler","year":"2004","unstructured":"Klenkler B, Sheardown H (2004) Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology. Exp Eye Res 79:677\u2013688","journal-title":"Exp Eye Res"},{"key":"3056_CR15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/08916930902831977","volume":"42","author":"D Mieliauskaite","year":"2009","unstructured":"Mieliauskaite D, Venalis P, Dumalakiene I, Venalis A, Distler J (2009) Relationship between serum levels of TGF-beta1 and clinical parameters in patients with rheumatoid arthritis and Sj\u00f6gren\u2019s syndrome secondary to rheumatoid arthritis. Autoimmunity 42:356\u2013358","journal-title":"Autoimmunity"},{"key":"3056_CR16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/rheumatology\/kel306","volume":"46","author":"P Szodoray","year":"2007","unstructured":"Szodoray P, Alex P, Chappell-Woodward CM, Madland TM, Knowlton N, Dozmorov I, Zeher M, Jarvis JN, Nakken B, Brun JG, Centola M (2007) Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system. Rheumatology (Oxford) 46:417\u2013425","journal-title":"Rheumatology (Oxford)"},{"key":"3056_CR17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1755-8794-6-17","volume":"6","author":"G Zaza","year":"2013","unstructured":"Zaza G, Granata S, Rascio F, Pontrelli P, Dell\u2019Oglio MP, Cox SN, Pertosa G, Grandaliano G, Lupo A (2013) A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. BMC Med Genomics 6:17","journal-title":"BMC Med Genomics"},{"key":"3056_CR18","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/ndt\/gfm804","volume":"23","author":"G Zaza","year":"2008","unstructured":"Zaza G, Pontrelli P, Pertosa G, Granata S, Rossini M, Porreca S, Staal FJ, Gesualdo L, Grandaliano G, Schena FP (2008) Dialysis-related systemic microinflammation is associated with specific genomic patterns. Nephrol Dial Transplant 23:1673\u20131681","journal-title":"Nephrol Dial Transplant"},{"key":"3056_CR19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.gene.2013.09.116","volume":"534","author":"A Kumar","year":"2014","unstructured":"Kumar A, Gupta V, Chaudhary M, Singh A, Sehajpal PK (2014) Depleted TGF-\u03b21 levels in end stage renal disease patients from North India. Gene 534:440\u2013443","journal-title":"Gene"},{"key":"3056_CR20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1525-139X.2012.01098.x","volume":"25","author":"G Mullaem","year":"2012","unstructured":"Mullaem G, Rosner MH (2012) Ocular problems in the patient with end-stage renal disease. Semin Dial 25:403\u2013407","journal-title":"Semin Dial"},{"key":"3056_CR21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1440-1797.2007.00805.x","volume":"12","author":"Z Akta\u015f","year":"2007","unstructured":"Akta\u015f Z, Ozdek S, Asli Din\u00e7 U, Aky\u00fcrek N, Atalay V, G\u00fcz G, Hasanreisoglu B (2007) Alterations in ocular surface and corneal thickness in relation to metabolic control in patients with chronic renal failure. Nephrology 12:380\u2013385","journal-title":"Nephrology"},{"key":"3056_CR22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0008-4182(04)80143-1","volume":"39","author":"M Ozdemir","year":"2004","unstructured":"Ozdemir M, Bakaris S, Ozdemir G, Buyukbese MA, Cetinkaya A (2004) Ocular surface disorders and tear function changes in patients with chronic renal failure. Can J Ophthalmol 39:526\u2013532","journal-title":"Can J Ophthalmol"},{"key":"3056_CR23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00417-012-2032-6","volume":"251","author":"JW Jung","year":"2013","unstructured":"Jung JW, Yoon MH, Lee SW, Chin HS (2013) Effect of hemodialysis (HD) on intraocular pressure, ocular surface, and macular changes in patients with chronic renal failure. Effect of hemodialysis on the ophthalmologic findings. Graefes Arch Clin Exp Ophthalmol 251:153\u2013162","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3056_CR24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1525-1594.2004.47160.x","volume":"28","author":"L Paczek","year":"2004","unstructured":"Paczek L, Gom\u00f3\u0142ka M, Niemczyk S, Bart\u0142omiejczyk I, Gerwatowska D, Sebekova K, Heidland A (2004) Serum growth factors in hemodialyzed patients. Artif Organs 28:314\u2013316","journal-title":"Artif Organs"},{"key":"3056_CR25","first-page":"61","volume":"120","author":"P August","year":"2009","unstructured":"August P, Sharma V, Ding R, Schwartz JE, Suthanthiran M (2009) Transforming growth factor beta and excess burden of renal disease. Trans Am Clin Climatol Assoc 120:61\u201372","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"3056_CR26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/089686089101100314","volume":"11","author":"S Dagogo-Jack","year":"1991","unstructured":"Dagogo-Jack S, Rodger RS, Kendall-Taylor P (1991) Increased salivary concentration of human epidermal growth factor in patient undergoing CAPD. Perit Dial Int 11:270\u2013273","journal-title":"Perit Dial Int"},{"key":"3056_CR27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1172\/JCI110964","volume":"72","author":"Y Oka","year":"1983","unstructured":"Oka Y, Orth DN (1983) Human plasma epidermal growth factor\/beta-urogastrone is associated with blood platelets. J Clin Invest 72:249\u2013259","journal-title":"J Clin Invest"},{"key":"3056_CR28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1525-139X.2006.00179.x","volume":"19","author":"D Kaw","year":"2006","unstructured":"Kaw D, Malhotra D (2006) Platelet dysfunction and end-stage renal disease. Semin Dial 19:317\u2013322","journal-title":"Semin Dial"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-015-3056-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-015-3056-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-015-3056-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T21:47:43Z","timestamp":1599083263000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-015-3056-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,31]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["3056"],"URL":"https:\/\/doi.org\/10.1007\/s00417-015-3056-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,31]]}}}